Kerala Ayurveda (BOM:530163) ROCE %: -70.59% (As of Mar. 2026)

What is Kerala Ayurveda ROCE %?

Kerala Ayurveda BOM:530163 -1.62% 47 ROCE % is -70.59% as of Mar. 2026. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹318.73 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kerala Ayurveda's annualized ROCE % for the quarter that ended in Mar. 2026 was -70.59%.

Kerala Ayurveda (BOM:530163) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kerala Ayurveda ROCE % Related Terms

Kerala Ayurveda ROCE % Historical Data

* Premium members only.

The historical data trend for Kerala Ayurveda's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kerala Ayurveda ROCE % Chart

Kerala Ayurveda Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

15.22

9.43

11.90

-18.19

-22.62

Kerala Ayurveda Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-111.16	35.64	-53.19	-19.22	-70.59

47GF Score

Kerala Ayurveda Ltd BOM:530163

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Kerala Ayurveda ROCE % Calculation

Kerala Ayurveda's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	-90.247	/	( ( (1287.62 - 879.75)	+	(1384.246 - 994.167) )	/ 2 )
	=	-90.247	/	( (407.87	+	390.079)	/ 2 )
	=	-90.247	/	398.9745
	=	-22.62 %

Kerala Ayurveda's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-275.364	/	( ( (0 - 0)	+	(1384.246 - 994.167) )	/ 1 )
	=	-275.364	/	( ( 0	+	390.079 )	/ 1 )
	=	-275.364	/	390.079
	=	-70.59 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -70.59% mean?

Kerala Ayurveda (BOM:530163) has a ROCE % of -70.59% as of Mar. 2026.

Is Kerala Ayurveda's ROCE % too high?

Kerala Ayurveda's current ROCE % is -70.59%. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Kerala Ayurveda's ROCE % compare to ZTS and UTHR?

Kerala Ayurveda's ROCE % of -70.59% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.03, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kerala Ayurveda's current ROCE % is -70.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Kerala Ayurveda stock overvalued right now?

Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹318.73, compared to a current price of ₹182.00 — trading 42.9% below its estimated fair value. The current ROCE % is -70.59%. Kerala Ayurveda's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current ROCE % is -70.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?

Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued. The current stock price of ₹182.00 is trading 42.9% below its estimated GF Value™ of ₹318.73. GuruFocus considers Kerala Ayurveda to be Possible Value Trap.

Key valuation signals for BOM:530163:

ROCE %: -70.59%
GF Value™: ₹318.73 vs. price of ₹182.00 (42.9% below fair value)
GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kerala Ayurveda Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:500009 BOM:524828 BOM:524790 BOM:531739 BOM:524412 BOM:524506 BOM:532649 BOM:533543 BOM:544409 BOM:531173 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Address XV/551, Athani Post, Nedumbassery, Ernakulam District, Ernakulam, KL, IND, 683585

Website https://www.keralaayurveda.biz

Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.

47GF Score

Get the complete analysis for BOM:530163

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹182.00

Price

₹318.73

GF Value

View BOM:530163 Analysis

See ROCE % data for all stocks →